Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial

Neuroinflammation has been proposed to impact symptomatology in patients with schizophrenia spectrum disorders. While previous studies have shown equivocal effects of treatments with add-on anti-inflammatory drugs such as Aspirin, N-acetylcysteine and Celecoxib, none have used a subset of prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Strube, Wolfgang, Aksar, Aslihan, Bauer, Ingrid, Barbosa, Susana, Benros, Michael, Blankenstein, Christiane, Campana, Mattia, Davidovic, Laetitia, Glaichenhaus, Nicolas, Falkai, Peter, Görlitz, Thomas, Hansbauer, Maximilian, Heilig, Daniel, Khalfallah, Olfa, Leboyer, Marion, Martinuzzi, Emanuela, Mayer, Susanne, Moussiopoulou, Joanna, Papazova, Irina, Perić, Natasa, Wagner, Elias, Schneider-Axmann, Thomas, Simon, Judit, Hasan, Alkomiet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374797/
https://www.ncbi.nlm.nih.gov/pubmed/36401749
http://dx.doi.org/10.1007/s00702-022-02566-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374797/
https://www.ncbi.nlm.nih.gov/pubmed/36401749
http://dx.doi.org/10.1007/s00702-022-02566-6

Ejemplares similares